David Christopher Mehlin 4
4 · Novo Integrated Sciences, Inc. · Filed Jun 2, 2023
Insider Transaction Report
Form 4
David Christopher Mehlin
DirectorPresident
Transactions
- Award
Stock Option (right to buy)
2023-05-31+2,000,000→ 2,000,000 totalExercise: $0.13From: 2023-05-31Exp: 2029-05-31→ Common Stock (2,000,000 underlying)
Holdings
- 81,950
Class A Common Stock
Footnotes (1)
- [F1]Represents the grant, by the issuer's Board of Directors, of an option to purchase 2,000,000 shares of the issuer's common stock at an exercise price of $0.132 per share. The option was fully vested and exercisable on the date of grant and expires on May 31, 2029.